Regen BioPharma Files Patent for mRNA Cancer Vaccine

Regen BioPharma has filed a provisional patent application covering utilization of dendritic cell technologies to augment efficacy of its patented mRNA cancer immunotherapeutic vaccine.
First Malaria Vaccine Prequalified by WHO

The World Health Organization has prequalified the first malaria vaccine, RTS,S/AS01 (also known as Mosquirix), manufactured by GSK, bringing it closer to reaching millions more children at risk of malaria.
TIL Therapy Found More Effective for Metastatic Melanoma Than Current Treatments

A Phase III clinical trial has found tumor-infiltrating lymphocyte therapy, a new treatment for advanced melanoma, was more effective than ipilimumab, the lading existing therapy.
Study Finds Universal Influenza B Vaccine Induces Broad and Lasting Protection

A study by researchers at Georgia State University’s Institute of Biomedical Sciences has found a new universal flu vaccine has been found to protect against influenza B viruses that offer broad defenses against different strains and improve immune protection.
FDA Approves Humira Biosimilar to Treat Autoimmune Disorders

The U.S. Food and Drug Administration has approved Samsung Bioepis; Halima (adalimumab-bwwd) for the treatment of several autoimmune disorders, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn’s disease.
Researchers Develop a New mRNA Vaccine to Treat Cancer

U.S. researchers have developed a new mRNA vaccine against cancer that delivers the drug directly to the lymphatic system and simulates a strong immune response.
New Test Identifies Patients at Risk of Severe COVID-19

U.S. scientists have developed a new genomic test that can predict a patient’s risk of developing severe COVID-19, an advance that could help doctors quickly begin tailored treatment.
Study Finds Pfizer’s RSV Vaccine Effective in Preventing Illness in Older Adults

Results of a recent study shows Pfizer’s experimental vaccine for respiratory syncytial virus is nearly 86 percent effective in preventing severe illness in older adults.
Experimental RSV Vaccine Shows Promise in Mice

An experimental vaccine shows promise for protecting mice from the respiratory syncytial virus, the pathogen that most commonly causes the chest infection bronchiolitis in young children.
$2 Million Awarded to Study Risks and Benefits of Social Media on Youth

Two million dollars in funding has been awarded to the American Academy of Pediatrics to establish a National Center of Excellence on Social Media and Mental Wellness.